Diabetes

REUS, Spain New research has found a Mediterranean diet can cut the risk of developing Type 2 diabetes by 50% in nondiabetics with high cardiovascular risk.

The study was conducted by Jordi Salas-Salvado and colleagues and published online in the Oct. 7 edition of Diabetes Care. This is the first randomized clinical trial to look specifically at use of the Mediterranean diet for the prevention of diabetes, the investigators said.

OAKLAND, Calif. Metabolic screenings may be beneficial to women prior to conceiving a child, as cardiometabolic risk factors that predict gestational diabetes are present before pregnancy, according to a new Kaiser Permanente study.

The study, published in the American Journal of Epidemiology, suggested that metabolic screenings could help identify those more likely to develop gestational diabetes mellitus, which typically occurs in the second or third trimester of pregnancy.

BALTIMORE —Remote management of diabetes increasingly is becoming a reality to day with WellDoc’s Diabetes-Manager system, which recently received 510(k) clearance from the Food and Drug Administration.

NEW YORK A new study published in the Journal of Epidemiology and Community Health found that the nation's average larger waist circumference is an indicator as to why the diabetes rate in America is higher than the rate in England.

James Smith, corporate chair of economics at the nonprofit organization RAND Corp., and researchers found that American men's waists were an average of 3 cm (1.5 in.) larger than those of men in England. Similarly, American women's waists were an average of 5 cm (2 in.) larger than those of women in England.

TEL AVIV, Israel A new Tel Aviv University study found a test used to diagnose gestational diabetes in women could be a key indicator to diagnosing Type 2 diabetes.

BETHESDA, Md. Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when taking an investigational treatment for Type 2 diabetes made by Spherix, the biotechnology company said Thursday.

Spherix announced results of a phase-3 trial of D-tagatose, which showed that the drug was more effective in American patients than in Indian patients.